rs121913351
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
Carcinoma of lung
0.800
GeneticVariation
UNIPROT
Molecular testing for selection of patients with lung cancer for epidermal growth factor receptor and anaplastic lymphoma kinase tyrosine kinase inhibitors: American Society of Clinical Oncology endorsement of the College of American Pathologists/International Association for the study of lung cancer/association for molecular pathology guideline.
25311215
2014
rs121913351
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
Carcinoma of lung
0.800
GeneticVariation
UNIPROT
Guideline Recommendations for Testing of ALK Gene Rearrangement in Lung Cancer: A Proposal of the Korean Cardiopulmonary Pathology Study Group.
24627688
2014
rs121913351
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
Carcinoma of lung
0.800
GeneticVariation
UNIPROT
Non-small cell lung cancer and precision medicine: a model for the incorporation of genomic features into clinical trial design.
24846033
2014
rs121913351
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
Carcinoma of lung
0.800
GeneticVariation
UNIPROT
Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.
23562183
2013
rs121913351
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
Carcinoma of lung
0.800
GeneticVariation
UNIPROT
Guideline Recommendations for EGFR Mutation Testing in Lung Cancer: Proposal of the Korean Cardiopulmonary Pathology Study Group.
23667368
2013
rs121913351
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
Carcinoma of lung
A
0.800
CausalMutation
CLINVAR
Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer.
23833300
2013
rs121913351
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
Carcinoma of lung
A
0.800
CausalMutation
CLINVAR
Kinase-impaired BRAF mutations in lung cancer confer sensitivity to dasatinib.
22649091
2012
rs121913351
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
Carcinoma of lung
A
0.800
CausalMutation
CLINVAR
Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations.
21483012
2011
rs121913351
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
Carcinoma of lung
A
0.800
CausalMutation
CLINVAR
Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines.
19238210
2009
rs121913351
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
Carcinoma of lung
A
0.800
CausalMutation
CLINVAR
Genetic predictors of MEK dependence in non-small cell lung cancer.
19010912
2008
rs121913351
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
Carcinoma of lung
A
0.800
CausalMutation
CLINVAR
BRAF and RAS mutations in human lung cancer and melanoma.
12460918
2002
rs121913351
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
Carcinoma of lung
A
0.800
CausalMutation
CLINVAR
Missense mutations of the BRAF gene in human lung adenocarcinoma.
12460919
2002
rs121913351
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
Carcinoma of lung
A
0.800
CausalMutation
CLINVAR
Mutations of the BRAF gene in human cancer.
12068308
2002
rs121913351
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
Carcinoma of lung
0.800
GeneticVariation
UNIPROT
Missense mutations of the BRAF gene in human lung adenocarcinoma.
12460919
2002
rs113488022
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
Carcinoma of lung
0.750
GeneticVariation
BEFREE
Accordingly, the combination of MEK inhibitor with EGFR inhibitor was effective at shrinking tumors in mouse model of BRAF non-V600E mutant lung cancer .
29348459
2018
rs113488022
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
Carcinoma of lung
0.750
GeneticVariation
BEFREE
Success of this design of clinical trials and practice was first demonstrated in EGFR inhibitor trials in lung cancer and has since been incorporated into subsequent targeted therapy trials including ALK-, ROS1-, and BRAF V600E -targeted therapies.
28786099
2017
rs113488022
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
Carcinoma of lung
T
0.750
CausalMutation
CLINVAR
Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer.
23833300
2013
rs113488022
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
Carcinoma of lung
0.750
GeneticVariation
BEFREE
BRAF V600E is an emerging drug target in lung cancer , but the clinical significance of non-V600 BRAF mutations in lung cancer and other malignancies is less clear.
24035431
2013
rs113488022
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
Carcinoma of lung
T
0.750
CausalMutation
CLINVAR
Molecular characterization of acquired resistance to the BRAF inhibitor dabrafenib in a patient with BRAF-mutant non-small-cell lung cancer.
23524406
2013
rs113488022
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
Carcinoma of lung
T
0.750
CausalMutation
CLINVAR
Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial.
22608338
2012
rs113488022
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
Carcinoma of lung
T
0.750
CausalMutation
CLINVAR
Kinase-impaired BRAF mutations in lung cancer confer sensitivity to dasatinib.
22649091
2012
rs113488022
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
Carcinoma of lung
T
0.750
CausalMutation
CLINVAR
A patient with BRAF V600E lung adenocarcinoma responding to vemurafenib.
22743296
2012
rs113488022
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
Carcinoma of lung
T
0.750
CausalMutation
CLINVAR
Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1.
22773810
2012
rs113488022
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
Carcinoma of lung
0.750
GeneticVariation
BEFREE
The incidence of BRAF mutations other than V600E is significantly higher in lung cancer than in melanoma.
21483012
2011
rs113488022
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
Carcinoma of lung
T
0.750
CausalMutation
CLINVAR
The incidence of BRAF mutations other than V600E is significantly higher in lung cancer than in melanoma.
21483012
2011